Tenax Therapeutics Future Growth
Future criteria checks 0/6
Tenax Therapeutics is forecast to grow earnings and revenue by 57.3% and 73.2% per annum respectively while EPS is expected to grow by 64.9% per annum.
Key information
57.3%
Earnings growth rate
64.9%
EPS growth rate
Biotechs earnings growth | 32.1% |
Revenue growth rate | 73.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 03 Apr 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | N/A | -20 | N/A | N/A | 1 |
12/31/2024 | N/A | -22 | N/A | N/A | 2 |
12/31/2023 | N/A | -13 | N/A | N/A | 2 |
12/31/2022 | N/A | -12 | N/A | N/A | 2 |
9/30/2022 | N/A | -12 | -12 | -12 | N/A |
6/30/2022 | N/A | -13 | -12 | -12 | N/A |
3/31/2022 | N/A | -11 | -11 | -11 | N/A |
12/31/2021 | N/A | -32 | -11 | -11 | N/A |
9/30/2021 | N/A | -32 | -10 | -10 | N/A |
6/30/2021 | N/A | -31 | -9 | -9 | N/A |
3/31/2021 | N/A | -31 | -10 | -10 | N/A |
12/31/2020 | N/A | -10 | -9 | -9 | N/A |
9/30/2020 | N/A | -10 | -9 | -9 | N/A |
6/30/2020 | N/A | -10 | -8 | -8 | N/A |
3/31/2020 | N/A | -9 | -8 | -8 | N/A |
12/31/2019 | N/A | -8 | -8 | -8 | N/A |
9/30/2019 | N/A | -15 | -7 | -7 | N/A |
6/30/2019 | N/A | -14 | -7 | -7 | N/A |
3/31/2019 | N/A | -15 | -6 | -6 | N/A |
12/31/2018 | N/A | -14 | -6 | -5 | N/A |
9/30/2018 | N/A | -6 | -6 | -6 | N/A |
6/30/2018 | N/A | -6 | -5 | -5 | N/A |
3/31/2018 | N/A | -7 | -10 | -10 | N/A |
12/31/2017 | N/A | -9 | -12 | -12 | N/A |
9/30/2017 | N/A | -37 | -14 | -14 | N/A |
6/30/2017 | N/A | -40 | -17 | -17 | N/A |
3/31/2017 | N/A | -42 | -17 | -17 | N/A |
12/31/2016 | N/A | -44 | -16 | -16 | N/A |
9/30/2016 | 0 | -19 | -18 | -18 | N/A |
6/30/2016 | 0 | -17 | N/A | -17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: YBO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: YBO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: YBO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: YBO is forecast to have no revenue next year.
High Growth Revenue: YBO is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if YBO's Return on Equity is forecast to be high in 3 years time